March 3, 2020 / 2:24 PM / a month ago

BRIEF-Celsion CEO Issues Letter To Stockholders

March 3 (Reuters) - Celsion Corp:

* CELSION CEO ISSUES LETTER TO STOCKHOLDERS

* CELSION CORP - DO NOT EXPECT ANY INTERRUPTION IN OUR SUPPLY OF THERMODOX OR GEN-1 FROM MANUFACTURING PARTNERS IN CHINA

* CELSION CORP - FINANCING FROM EQUITY FUNDRAISE EXTENDS OPERATING CASH RUNWAY WELL INTO 2021

* CELSION CORP - DO NOT EXPECT ANY MAJOR DISRUPTIONS IN PATIENT FOLLOW-UP OR DATA REPORTING OWING TO COVID-19 FOR PHASE III OPTIMA STUDY

* CELSION CORP - EARLY PHASE I DATA FROM OVATION 2 STUDY IS EXPECTED BY END OF CURRENT QUARTER Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below